Masoud Tavazoie, M.D., Ph.D.
Chief Executive Officer & Co-founder
Masoud is co-founder, Board Director, and the Chief Executive Officer of Inspirna.
David Darst, M.B.A.
CHIEF OPERATING OFFICER
David co-leads Inspirna’s financing, corporate development, and drug development efforts.
Robert Wasserman, M.D.
Chief Medical Officer
Bob oversees clinical development of Inspirna’s first-in-class programs.
Isabel Kurth, Ph.D.
VP of Research
Isabel leads Inspirna’s research and target discovery efforts.
Stephen Wald, M.S.
SVP of Chemistry & Pharmaceutical Sciences
Steve is responsible for chemical, analytical and formulation development, and manufacturing scale-up, of Inspirna’s drug candidates.
Naftali Bechar, M.D.
SVP of Clinical Development
Naftali supports our CMO in managing clinical development of our novel drug candidates.
Corey Sohmer, M.B.A.
VP of Finance & Accounting
Corey brings to Inspirna more than 25 years of progressive leadership experience in finance and accounting.
Michael Szarek, Ph.D.
VP of Clinical & Regulatory Affairs
Michael leads clinical and regulatory affairs at Inspirna.
Anne Assmus, Ph.D.
Head of Business Development
Narayan Lebaka
Senior Director of Data Management
Narayan Lebaka heads Clinical Data Management at Inspirna. He is responsible for all clinical trial data deliverables through strategic partnerships with CROs.
Shugaku Takeda, PhD
Associate Director of Research
Shugaku leads Inspirna’s research and development efforts focused on biologics development.
Scott Spector
Head of Clinical Operations (RGX-202)
Scott is an accomplished clinical development executive with 20 years of pharmaceutical product development experience.
